Plasma Exosome-Derived Sentrin SUMO-Specific Protease 1: A Prognostic Biomarker in Patients With Osteosarcoma

Plasma Exosome-Derived Sentrin SUMO-Specific Protease 1: A Prognostic Biomarker in Patients With Osteosarcoma

BackgroundThe exosomes contain many important proteins that can be used for early tumor diagnosis or patient prognosis analysis. In this study, we investigated plasma exosome-derived sentrin SUMO-specific protease 1 (SENP1) levels as a prognostic biomarker in patients with osteosarcoma.MethodsThe ex...

Full description

Bibliographic Details
Main Authors: Li Wang, Jian Wu, Shu Song, Haining Chen, Yong Hu, Buwei Xu, Jinbo Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
sentrin sumo-specific protease 1 (SENP1)
osteosarcoma
exosomes
prognostic biomarker
small ubiquitin-related modifier (SUMO)
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.625109/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.625109/full

Similar Items